MA42166B1 - Syringe - Google Patents
SyringeInfo
- Publication number
- MA42166B1 MA42166B1 MA42166A MA42166A MA42166B1 MA 42166 B1 MA42166 B1 MA 42166B1 MA 42166 A MA42166 A MA 42166A MA 42166 A MA42166 A MA 42166A MA 42166 B1 MA42166 B1 MA 42166B1
- Authority
- MA
- Morocco
- Prior art keywords
- syringe
- relates
- present
- small volume
- ophthalmic injections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
- A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
- A61M2005/3104—Caps for syringes without needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M2005/3131—Syringe barrels specially adapted for improving sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
- A61M2005/3139—Finger grips not integrally formed with the syringe barrel, e.g. using adapter with finger grips
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
La présente invention concerne une seringue, plus particulièrement une seringue de petit volume, telle qu'une seringue appropriée pour des injections ophtalmiques.The present invention relates to a syringe, more particularly to a small volume syringe, such as a syringe suitable for ophthalmic injections.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12174860 | 2012-07-03 | ||
EP12189649 | 2012-10-23 | ||
DE202012011016U DE202012011016U1 (en) | 2012-07-03 | 2012-11-16 | Aflibercept syringe |
Publications (2)
Publication Number | Publication Date |
---|---|
MA42166A1 MA42166A1 (en) | 2018-12-31 |
MA42166B1 true MA42166B1 (en) | 2019-09-30 |
Family
ID=47325019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA42166A MA42166B1 (en) | 2012-07-03 | 2015-01-02 | Syringe |
Country Status (3)
Country | Link |
---|---|
AU (2) | AU2012101678B4 (en) |
DE (3) | DE202012011016U1 (en) |
MA (1) | MA42166B1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20200175A1 (en) | 2012-07-03 | 2017-06-16 | Novartis Ag | Syringe |
CA2947456C (en) * | 2014-05-12 | 2023-03-14 | Formycon Ag | Pre-filled plastic syringe containing a vegf antagonist |
JP2019501687A (en) | 2015-11-18 | 2019-01-24 | フォーマイコン アーゲーFormycon Ag | Prefilled plastic syringe containing VEGF antagonist |
US10537683B2 (en) | 2016-11-03 | 2020-01-21 | Johnson & Johnson Surgical Vision, Inc. | Syringe finger grip |
PE20221790A1 (en) * | 2019-12-06 | 2022-11-25 | Regeneron Pharma | ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6243938B1 (en) * | 1998-03-17 | 2001-06-12 | Becton, Dickinson And Company | Low silicone plastic prefillable syringe |
US20050043220A1 (en) * | 2002-11-08 | 2005-02-24 | Guyer David R. | Methods and compositions for treating macular degeneration |
US20080027113A1 (en) * | 2003-09-23 | 2008-01-31 | Zeldis Jerome B | Methods of Using and Compositions Comprising Immunomodulatory Compounds for Treatment and Management of Macular Degeneration |
KR100897379B1 (en) | 2004-06-08 | 2009-05-14 | 쳉두 캉홍 바이오테크놀로지스 코. 리미티드 | Angiogenesis-inhibiting chimeric protein and the use |
WO2007035621A1 (en) * | 2005-09-16 | 2007-03-29 | (Osi) Eyetech, Inc. | Ophthalmic syringe |
AU2012202859B2 (en) * | 2006-06-16 | 2014-12-04 | Regeneron Pharmaceuticals, Inc. | VEGF antagonist formulations suitable for intravitreal administration |
WO2007149334A2 (en) * | 2006-06-16 | 2007-12-27 | Regeneron Pharmaceuticals, Inc. | Vegf antagonist formulations suitable for intravitreal administration |
CN102272148A (en) * | 2008-11-03 | 2011-12-07 | 分子组合公司 | Binding proteins inhibiting the vegf-a receptor interaction |
US20110276005A1 (en) * | 2008-12-03 | 2011-11-10 | Taisei Kako Co., Ltd. | Syringe |
US20120076787A1 (en) * | 2009-05-28 | 2012-03-29 | Peter Adamson | Combination of a tnf-alpha antagonist and a vegf antagonist for use in the treatment or prevention of diseases of the eye |
AU2011206104A1 (en) * | 2010-01-14 | 2012-07-12 | Nagoya City University | Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
AR081361A1 (en) | 2010-04-30 | 2012-08-29 | Molecular Partners Ag | MODIFIED UNION PROTEINS THAT INHIBIT THE RECEPTOR INTERACTION OF THE VASCULAR ENDOTELIAL GROWTH FACTOR FROM GLICOPROTEIN TO VEGF-A |
-
2012
- 2012-11-16 AU AU2012101678A patent/AU2012101678B4/en not_active Expired
- 2012-11-16 DE DE202012011016U patent/DE202012011016U1/en not_active Expired - Lifetime
- 2012-11-16 AU AU2012101677A patent/AU2012101677B4/en not_active Expired
- 2012-11-23 DE DE202012011260U patent/DE202012011260U1/en not_active Ceased
- 2012-11-23 DE DE202012011259U patent/DE202012011259U1/en not_active Expired - Lifetime
-
2015
- 2015-01-02 MA MA42166A patent/MA42166B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2012101678A4 (en) | 2012-12-20 |
AU2012101678B4 (en) | 2013-01-24 |
DE202012011259U1 (en) | 2013-02-11 |
DE202012011260U1 (en) | 2013-02-11 |
AU2012101677A4 (en) | 2012-12-13 |
DE202012011016U1 (en) | 2012-11-28 |
MA42166A1 (en) | 2018-12-31 |
AU2012101677B4 (en) | 2012-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA37740A1 (en) | Syringe | |
AU2016204248A1 (en) | Boron-Containing Molecules | |
AU2015208932A8 (en) | (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase I inhibitors | |
IN2015DN03029A (en) | ||
IN2015DN00598A (en) | ||
MA42166B1 (en) | Syringe | |
TR201821285T4 (en) | Pharmaceutical formulations containing a CCR3 antagonist. | |
TR201909923T4 (en) | Composition containing the pyrazole derivative for the prevention or treatment of kidney disease. | |
MX2014002625A (en) | Novel compositions for producing cast polyamides. | |
MA34978B1 (en) | ANTIDOTES FOR ANTICOAGULANTS | |
EA201590651A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING REBAMIPID | |
EA201491496A1 (en) | HSP90 C-END DOMAIN INHIBITORS | |
PH12016501183A1 (en) | Novel compound for treatment of severe hypoglycemia | |
PH12016501182A1 (en) | Novel compound for treatment of severe hypoglycemia | |
PH12016501184A1 (en) | Novel compound for treatment of severe hypoglycemia | |
TR201007106A1 (en) | Cefpodoxime proxetil formulations. | |
CY1124956T1 (en) | SYRINGE | |
IN2015KN00386A (en) | ||
UA105703C2 (en) | 7-bromo-5-phenyl-3-arylamino-1,2-dihydro-3h-1,4-benzdiazepin-2-ones as analgetic agents | |
UA78360U (en) | Use of 1-[n-(isononyl-2-hydroxybenzolmethan)-1-(2-ethylamine)-2-(alkenyl oleinic acid)-4,5-dihydro-1h-imidazolin-dioleate as antioxidant and detergent additive for hydrocarbon adsorbents | |
IN2013CH05395A (en) | ||
TN2010000225A1 (en) | Injectable liquid paracetamol formulation | |
UA78359U (en) | Use of 1-[n-(isononyl-2-hydroxybenzolmethan)-1-(2-ethylamine)-2-(alkyl, alkenyl fatty acids of tall oil)-4,5-dihydro-1h-imidazolin-ditallate as antioxidant and detergent additive for hydrocarbon adsorbents | |
UA78358U (en) | Use of 1-[n-(diisononyl-2-hydroxybenzolmethan)-1-(2-ethylamine)-2-(alkyl, alkenyl fatty acids of tall oil)-4,5-dihydro-1h-imidazolin-ditallate as antioxidant and detergent additive for hydrocarbon adsorbents | |
UA78284U (en) | 5,11- dibenzyl -8-thioxo-13-(2-chlorophenyl)-3,5,7,11- tetraazatricyclo[7.3.1.02,7]tridec-2-ene-1,9-dicarbonitrile |